ADVENZYMESAdvanced Enzyme Technologies Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on ADVENZYMES — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 21.6% YoY
- • Profit growth: 62.0% YoY
- • Debt/Equity: 0.02
- • MACD: bullish
- • 6-month vs NIFTY: +9.4% relative
- • Beta: 0.69
Bull case
- • Revenue growth: 21.6% YoY
- • Profit growth: 62.0% YoY
- • Debt/Equity: 0.02
- • MACD: bullish
Bear case
- • Dividend yield: 0.46%
- • RSI: 41
- • Price vs EMA21: below
- • 1-month return: -2.5%
Key risks
- • Momentum is fading versus the broader market
- • Dividend yield: 0.46%
- • RSI: 41
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹8.81). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.